News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Nico Gagelmann: Registration Is Open for the 10th Congress on COSTEM
Nico Gagelmann
Aug 20, 2025, 15:57

Nico Gagelmann: Registration Is Open for the 10th Congress on COSTEM

Nico Gagelmann, Hematologist at University Hospital Hamburg-Eppendorf, Young National Society Ambassador at European Hematology Association (EHA), and Chair of the CAR-T for plasma cell disorder committee at The EBMT, shared a post on X:

“Join us for the 10th COSTEM (Controversies in Stem Cell Transplantation and Cellular Therapies).

25-28 September in Berlin

Unique profile, with voting before and after each debate.

Register and see the programme.

DM me if you may need financial support.

See you in Berlin, let’s debate!

Impression from last year.”

Proceed to the video attached to the post.

Nico Gagelmann: Registration Is Open for the 10th Congress on COSTEM

More posts featuring Nico Gagelmann.

cancer Controversies in Stem Cell Transplantation and Cellular Therapies costem COSTEM 2025 Nico Gagelmann OncoDaily Oncology
Special Coverage
Voices
Aug 20, 2025, 15:57
Nico Gagelmann: Registration Is Open for the 10th Congress on COSTEM
Voices
Aug 20, 2025, 15:57
Nieves Martinez Lago: NETs/NENs Gain Dedicated Category at ASCO GI26
Science
Aug 20, 2025, 15:55
ASCO25 Liquid Biopsy Highlights - International Society of Liquid Biopsy
Voices
Aug 20, 2025, 15:54
Chrystal Paulos Has Been Awarded V Foundation All-Star Grant - Winship Cancer Institute of Emory University
Voices
Aug 20, 2025, 15:52
Kirsten Efremov: Strengthening Patient Engagement in the Adolescent and Young Adult Cancer Community
Insight
Aug 20, 2025, 15:42
Joshua Palmer: Pre-Operative Versus Post-Operative Fractionated Stereotactic Radiotherapy
Immune Oncology
Aug 20, 2025, 15:42
New IO Paper Alert: Neutrophil-to-Lymphocyte Ratio as a Predictive Biomarker for First-Line Immunotherapy Outcomes in HCC.
Voices
Aug 20, 2025, 15:41
Rob Winn: The NIH's 15% Indirect Cost Cap - A Misunderstanding of Research Reality
Opinion
Aug 20, 2025, 15:36
Elisabeth Potter: The Impact of Rising Insurance Costs on Breast Cancer Treatment Choices
Voices
Aug 20, 2025, 15:32
Minhua Chu: BNT327 (Pumitamig) Shows Promising Efficacy in ES-SCLC in Phase II Trial
Dialogues
Aug 20, 2025, 15:27
How Can We Accelerate New Drug Development for Children with Cancer? | Second Global Oncothon
Voices
Aug 20, 2025, 15:24
The Role of Radiotherapy and AI in Cancer Treatment at National Summit - National Cancer Institute of Kenya